Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2014 pubmed

[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis].

Zong. Yu Y; Li. Jiping J

Key Findings

  • LL-37 is the sole human cathelicidin peptide identified to date.
  • It is an integral component of the innate immune response.
  • Evidence suggests LL-37 contributes to the pathogenesis of chronic sinusitis.

Practical Outcomes

  • For biohackers, the main takeaway is that LL-37 is a potential target for future sinusitis therapies, but the review does not provide specific dosing or supplementation advice. Understanding its role may help you follow upcoming research on immune‑modulating strategies for sinus health.

Summary

LL-37 is the only known human cathelicidin peptide and plays a key part in our innate immune system. This review explains how LL-37 is involved in the development of chronic sinusitis, a long‑lasting inflammation of the sinuses. The authors highlight that researchers are paying more attention to LL-37’s role in this condition.

Abstract

The purpose of this review is to explain the function of LL-37 in the pathogenesis of chronic sinusitis. LL-37 is the only human cathelicidin identified so far. LL-37 is an integral part of the innate immune,the role of which in chronic sinusitis is attracting more and more s attention.

Study Information

Provider

pubmed

Year

2014